List of Tables
Summary Table: Global Market for Life Science Tools, by Region, Through 2024
Table 1: Global Market for Academic Life Science Tools, by Region, Through 2024
Table 2: Global Market for Clinical Life Science Tools, by Region, Through 2024
Table 3: Global Market for Biotech Life Science Tools, by Region, Through 2024
Table 4: Global Market for GMP Proteins, by Region, Through 2024
Table 5: Global Market for Academic GMP Proteins, by Region, Through 2024
Table 6: Global Market for Clinical GMP Proteins, by Region, Through 2024
Table 7: Global Market for Biotech GMP Proteins, by Region, Through 2024
Table 8: Global Market for Media, by Region, Through 2024
Table 9: Global Market for Academic Media, by Region, Through 2024
Table 10: Global Market for Clinical Media, by Region, Through 2024
Table 11: Global Market for Biotech Media, by Region, Through 2024
Table 12: Global Market for Cell Separation, by Region, Through 2024
Table 13: Global Market for Academic Cell Separation, by Region, Through 2024
Table 14: Global Market for Biotech Cell Separation, by Region, Through 2024
Table 15: Global Market for Clinical Cell Separation, by Region, Through 2024
Table 16: Global Market for Gene Vectors, by Region, Through 2024
Table 17: Global Market for Academic Gene Vectors, by Region, Through 2024
Table 18: Global Market for Clinical Gene Vectors, by Region, Through 2024
Table 19: Global Market for Biotech Gene Vectors, by Region, Through 2024
Table 20: Global Market for Cytokine Release Syndrome Testing, by Region, Through 2024
Table 21: Global Market for Academic Cytokine Release Syndrome Testing, by Region, Through 2024
Table 22: Global Market for Clinical Cytokine Release Syndrome Testing, by Region, Through 2024
Table 23: Global Market for Biotech Cytokine Release Syndrome Testing, by Region, Through 2024
Table 24: Global Market for GMP Antibodies, by Region, Through 2024
Table 25: Global Market for Academic GMP Antibodies, by Region, Through 2024
Table 26: Global Market for Clinical GMP Antibodies, by Region, Through 2024
Table 27: Global Market for Biotech GMP Antibodies, by Region, Through 2024
Table 28: Global Market for Leukapheresis, by Region, Through 2024
Table 29: Global Market for Academic Leukapheresis, by Region, Through 2024
Table 30: Global Market for Biotech Leukapheresis, by Region, Through 2024
Table 31: Global Market for Clinical Leukapheresis, by Region, Through 2024
Table 32: Global Market for Bioreactors, by Region, Through 2024
Table 33: Global Market for Academic Bioreactors, by Region, Through 2024
Table 34: Global Market for Biotech Bioreactors, by Region, Through 2024
Table 35: Global Market for Clinical Bioreactors, by Region, Through 2024
Table 36: Global Market for Research Use-Only Immunoassays, by Region, Through 2024
Table 37: Global Market for Academic Research Use-Only Immunoassays, by Region, Through 2024
Table 38: Global Market for Clinical Research Use-Only Immunoassays, by Region, Through 2024
Table 39: Global Market for Biotech Research Use-Only Immunoassays, by Region, Through 2024
Table 40: Global Market for Research Use-Only Multiplex Immunoassays, by Region, Through 2024
Table 41: Global Market for Academic Research-Use Only Multiplex Immunoassays, by Region, Through 2024
Table 42: Global Market for Clinical Research Use-Only Multiplex Immunoassays, by Region, Through 2024
Table 43: Global Market for Biotech Research Use-Only Multiplex Immunoassays, by Region, Through 2024
Table 44: Global Market for Cancer Life Science Tools, by Region, Through 2024
Table 45: Global Market for Blood Disorder Life Science Tools, by Region, Through 2024
Table 46: Global Market for Life Science Tools for Other Diseases, by Region, Through 2024
Table 47: Global Market for Cancer GMP Proteins, by Region, Through 2024
Table 48: Global Market for Blood Disorder GMP Proteins, by Region, Through 2024
Table 49: Global Market for GMP Proteins for Other Diseases, by Region, Through 2024
Table 50: Global Market for Cancer Media, by Region, Through 2024
Table 51: Global Market for Blood Disorder Media, by Region, Through 2024
Table 52: Global Market for Media for Other Diseases, by Region, Through 2024
Table 53: Global Market for Cancer Cell Separation, by Region, Through 2024
Table 54: Global Market for Blood Disorder Cell Separation, by Region, Through 2024
Table 55: Global Market for Cell Separation for Other Diseases, by Region, Through 2024
Table 56: Global Market for Cancer Gene Vectors, by Region, Through 2024
Table 57: Global Market for Blood Disorder Gene Vectors, by Region, Through 2024
Table 58: Global Market for Gene Vectors for Other Diseases, by Region, Through 2024
Table 59: Global Market for Cancer Cytokine Release Syndrome Testing, by Region, Through 2024
Table 60: Global Market for Blood Disorder Cytokine Release Testing, by Region, Through 2024
Table 61: Global Market for Cytokine Release Testing for Other Diseases, by Region, Through 2024
Table 62: Global Market for Cancer GMP Antibodies, by Region, Through 2024
Table 63: Global Market for Blood Disorder GMP Antibodies, by Region, Through 2024
Table 64: Global Market for GMP Antibodies for Other Diseases, by Region, Through 2024
Table 65: Global Market for Cancer Leukapheresis, by Region, Through 2024
Table 66: Global Market for Blood Disorder Leukapheresis, by Region, Through 2024
Table 67: Global Market for Leukapheresis for Other Diseases, by Region, Through 2024
Table 68: Global Market for Cancer Bioreactors, by Region, Through 2024
Table 69: Global Market for Blood Disorder Bioreactors, by Region, Through 2024
Table 70: Global Market for Bioreactors for Other Diseases, by Region, Through 2024
Table 71: Global Market for Cancer Immunoassays, by Region, Through 2024
Table 72: Global Market for Blood Disorder Immunoassays, by Region, Through 2024
Table 73: Global Market for Immunoassays for Other Diseases, by Region, Through 2024
Table 74: Global Market for Cancer Multiplex Immunoassays, by Region, Through 2024
Table 75: Global Market for Blood Disorder Multiplex Immunoassays, by Region, Through 2024
Table 76: Global Market for Multiplex Immunoassays for Other Diseases, by Region, Through 2024